OTC: COGZF - Cogstate Limited

半年間の収益性: -25.93%
セクタ: Healthcare

プロモーションスケジュール Cogstate Limited


会社について

Cogstate Limited, a neuroscience technology company, provides computerized cognitive tests and electronic clinical outcome assessment solutions. The company's cognitive services include project management, data management, scientific consulting, statistical analysis, scales procurement, rater training, and monitoring solutions. It operates in Clinical Trials and Healthcare segments.

さらに詳しく
The Clinical Trials segment provides technology and associated services that are used to quantify the effect of diseases and drugs, and devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical and biotechnology companies. The Healthcare segment provides Cognigram, a system for regular and standardized testing to assist primary care physicians and/or hospitals in the early detection of cognitive decline. As of June 30, 2022, it had participated in approximately 1,800 academic research. Cogstate Limited was incorporated in 1999 and is based in Melbourne, Australia.

EBITDA -0.0047
Industry Health Care Technology
P/BV 1.16
P/E 37.25
P/S 0.5359
Sector Health Care
Валюта usd
Валюта отчета usd
Выручка 0.0311
Сайт https://www.cogstate.com
Цена ао 0.83
Число акций ао 0.17319 млрд
1日あたりの価格変動: +0.8065% (0.5952)
週ごとの価格変動: +1.69% (0.59)
月ごとの料金変更: -6.25% (0.64)
3ヶ月間の価格変動: -20% (0.75)
半年間の価格変動: -25.93% (0.81)
年間の価格変動: -28.57% (0.84)
3年間の価格推移: -63.86% (1.66)
5年間の価格推移: -34.07% (0.91)
年初からの価格変動: -38.78% (0.98)

過小評価

名前 意味 学年
P/S 2.87 6
P/BV 3.05 5
P/E 22.88 6
EV/EBITDA 0 0
合計: 6.13

効率

名前 意味 学年
ROA, % 9.42 3
ROE, % 13.32 4
合計: 2.83

配当金

名前 意味 学年
Div yield, % 0 0
DSI 0 0
合計: 0

義務

名前 意味 学年
Debt/EBITDA 0 10
合計: 10

成長の衝動

名前 意味 学年
収益性 Revenue, % 25.88 4
収益性 Ebitda, % -221.06 0
収益性 EPS, % -382.41 0
合計: 0.8

機関 音量 共有, %
Bard Financial Services, INC. 12500 0.01



スーパーバイザー 役職 支払い 生年
Prof. Paul Maruff BBSc (Hons), Ph.D. Founder & Chief Innovation Officer N/A
Mr. Darren Watson Chief Financial Officer 356.18k
Mr. Kenneth Billard Chief Commercial Officer 417.18k
Ms. Rachel Colite Executive VP of Clinical Trials 290.87k
Ms. Kristi Geddes General Counsel, Joint Company Secretary & Director N/A
Mr. David James Franks BEc, C.A., F Fin, J.P. Joint Company Secretary N/A 1970 (54 年)
Mr. Bradley John O'Connor B.Bus, C.A., CA CEO, MD & Executive Director

住所: Australia, Melbourne. VIC, 367 Collins Street - Googleマップで開く, Yandexマップを開く
Webサイト: https://www.cogstate.com